Lenvatinib plus everolimus for patients with metastatic kidney cancer
The treatment of heavily pretreated patients with metastatic kidney cancer [...]
The treatment of heavily pretreated patients with metastatic kidney cancer [...]
Cabozantinib is a tyrosine kinase inhibitor that is used [...]
Kidney cancers often have mutations in a gene called the von Hippel-Lindau [...]
Maintaining good health-related quality of life is important for all [...]
At the American Society of Clinical Oncology (ASCO) Annual Meeting [...]
This phase 2 clinical trial (ENTRATA) looked at how safe [...]
This phase 1 clinical trial looked at the safety, tolerability, [...]
Results from the phase 3 CLEAR study, presented at the [...]
Treating non-clear cell renal cell carcinoma (RCC) is challenging because [...]
In this phase 2 clinical trial, a combination of everolimus [...]